Tower Research Capital LLC (Trc) Immunome Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Immunome Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,479 shares of IMNM stock, worth $13,473. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,479
Previous 2,002
26.12%
Holding current value
$13,473
Previous $24,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IMNM
# of Institutions
122Shares Held
47.1MCall Options Held
322KPut Options Held
1.91M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.76MShares$52.5 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.89MShares$44.5 Million4.67% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$35.3 Million2.46% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$34.2 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.49MShares$31.8 Million0.03% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $110M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...